{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Vikas", "organization": "", "rank": 1, "lastname": "BAJAJ"}], "original": "By VIKAS BAJAJ"}, "news_desk": "Editorial", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "legacy": {"wide": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"kicker": "Taking Note", "content_kicker": "Taking Note", "main": "The Pharma C.E.O. Who Wants to Lower Drug Prices"}, "print_page": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "2", "name": "subject"}], "snippet": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline....", "source": "The New York Times", "lead_paragraph": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline.", "word_count": "700", "pub_date": "2016-10-21T17:03:25+0000", "subsection_name": null, "blog": [], "type_of_material": "Editorial", "section_name": "Opinion", "web_url": "http://www.nytimes.com/2016/10/21/opinion/the-pharma-ceo-who-wants-to-lower-drug-prices.html", "_id": "580a4a6495d0e022439c4868"}